A Most Memorable Hockey Tribute Happened in Columbus Last Night
That Nate Silver Trendline Is Not Good News for Kamala
How Pelosi Responds When Asked If She Thought Biden Has Forgiven Her
Joe Biden Tried to Attack Trump. He Only Showed He's Mentally Cooked.
'Adios Michigan': Kamala Fails to Secure Another Key Endorsement
Harris' Town Hall Event With Charlamagne Got Roasted in the Comments
DeSantis Announces Update to Viral Video of Highway Patrol Rescuing Dog Abandoned as...
Georgia Judge Blocks Ballot Hand Counting Rule
Why This Average American Is Voting for Donald Trump…Again
Dems in Disarray: AOC and Fetterman Fighting Online Over Israel
Did You Notice Anything Odd at the Victoria's Secret Fashion Show?
Reality Again Debunks the Left's Ugly Lies and Misinformation About Georgia's Election Law
U.S. Army Training Materials Labeled Pro-Life Groups As Terrorists, Lawsuit Says
Catholic Group Doesn’t Buy Whitmer’s Apology for Stunt Mocking Catholics
Biden Administration Chooses Politics Over National Security and Norms
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement